Search Results for: "amgen v hospira filgrastim"

BPCIA Litigations

Pending U.S. District Court BPCIA Litigations Litigation Accused Biosimilar [status] Reference Product Complaint Filed Status/Outcome District Court Appeal Amgen v. Hospira, No. 20-201 (D. Del.) NYVEPRIA (pegfilgrastim-apgf) [approved] NEULASTA [litigation #5] Feb. 11, 2020 Pending Genentech v. Samsung Bioepis, No. 20-859 (D. Del.) SB8 (bevacizumab biosimilar) [not approved] AVASTIN [litigation…

Read More